Pharmaceutical News

RSS

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.

1 Nov 2012

Nisin may slow or prevent squamous cell head and neck cancers

Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.

1 Nov 2012

AP examines future of AMFm following conflicting reports on program's success

The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

1 Nov 2012

New track-and-trace proposal advanced to combat drug counterfeiting, gray market

The bipartisan track and trace draft legislation released last week would allow drugs to be authenticated throughout the supply chain, which could help combat counterfeiting as well as the so-called gray market that's been highlighted in the drug shortage crisis, Democratic staffers who worked on the draft said.

1 Nov 2012

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.

1 Nov 2012

FDA: Ameridose voluntarily recalls all unexpired drug products in circulation

The U.S. Food and Drug Administration announced today that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation.

1 Nov 2012

Access to malaria drugs transformed by new global subsidy

A new international scheme providing lifesaving antimalarial drugs at cheap subsidised prices has rapidly transformed access to effective artemisinin combination therapies (ACTs) in seven African countries accounting for a quarter of the world’s malaria cases, and could save millions of lives.

31 Oct 2012

SSRIs should be prescribed with great caution to those attempting to get pregnant

Elevated risk of miscarriage, preterm birth, neonatal health complications and possible longer term neurobehavioral abnormalities, including autism, suggest that a class of antidepressants known as selective serotonin reuptake inhibitors (SSRI) should only be prescribed with great caution and with full counseling for women experiencing depression and attempting to get pregnant, say researchers at Beth Israel Deaconess Medical Center, Tufts Medical Center and MetroWest Medical Center.

31 Oct 2012

EC grants conditional marketing authorisation for ADCETRIS to treat hematological cancers

Takeda Pharmaceutical Company Limited and Millennium: The Takeda Oncology Company, today announced that the European Commission has granted conditional marketing authorisation for ADCETRIS (brentuximab vedotin) for two indications.

31 Oct 2012

Fla. suspends compounding pharmacy as report slams lax oversight

The fallout from a deadly meningitis outbreak continues as Florida suspends operations at one compounding pharmacy, while a report finds state oversight of the facilities lacking.

31 Oct 2012

Cost of searching for fountain of youth exceeds cost for medications to treat chronic disease

The cost of searching for the fountain of youth has become increasingly expensive and now exceeds the cost for medications used to treat chronic disease, according to new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif.

31 Oct 2012

SSRIs should be prescribed with great caution to those attempting to get pregnant

31 Oct 2012

Hormone therapy increases risk of heart attack or dying in women with metabolic syndrome

A new analysis of the Women's Health Initiative (WHI) trials show that women who had metabolic syndrome before they started hormone therapy had a greatly increased risk of heart attack or dying of heart disease. Women who didn't have metabolic syndrome beforehand showed no increased risk.

31 Oct 2012

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst Pharmaceuticals, Inc. announced the withdrawal of its Investigational New Drug application (IND) for the antiviral nucleoside, BCX5191, following a discussion with the U.S. Food and Drug Administration (FDA).

31 Oct 2012

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).

31 Oct 2012

Complix to accelerate development of CPABs against intracellular disease targets

Complix announces that it has been awarded a €1.9 million grant (approximately USD$2.4 million) from the Flanders government through IWT (Agency for Innovation by Science and Technology in Flanders).

30 Oct 2012

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.

30 Oct 2012

Sprint Bioscience, TPP partner to develop small molecule inhibitors of choline kinase for cancer

TPP Global Development Ltd (TPP) enters into a collaboration with Sprint Bioscience AB to develop small molecule inhibitors of choline kinase as human therapeutics for the treatment of cancer.

30 Oct 2012

Study suggests 2004 lawsuit fueled big spending on epilepsy drugs

In 2004, Pfizer, the world's largest drug company, agreed to plead guilty and pay more than $430 million to settle charges it had illegally marketed the epilepsy drug Neurontin for unapproved uses.

30 Oct 2012

Adolescent males at increased risk of reporting longtime OTC drug use

As crackdowns get tougher on alcohol, tobacco sales, and illicit drugs, there's a growing trend among youth to turn to another source to get a high: their parent's medicine cabinet. A new University of Cincinnati study suggests adolescent males are at a higher risk of reporting longtime use of over-the-counter drugs, compared with their female peers.

30 Oct 2012

Pharmaceutical News

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

Nisin may slow or prevent squamous cell head and neck cancers

AP examines future of AMFm following conflicting reports on program's success

New track-and-trace proposal advanced to combat drug counterfeiting, gray market

Novartis resumes distribution of two seasonal influenza vaccines in Canada

FDA: Ameridose voluntarily recalls all unexpired drug products in circulation

Access to malaria drugs transformed by new global subsidy

SSRIs should be prescribed with great caution to those attempting to get pregnant

EC grants conditional marketing authorisation for ADCETRIS to treat hematological cancers

Fla. suspends compounding pharmacy as report slams lax oversight

Cost of searching for fountain of youth exceeds cost for medications to treat chronic disease

SSRIs should be prescribed with great caution to those attempting to get pregnant

Hormone therapy increases risk of heart attack or dying in women with metabolic syndrome

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

FDA accepts Sunovion’s two LATUDA sNDAs for review

Complix to accelerate development of CPABs against intracellular disease targets

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

Sprint Bioscience, TPP partner to develop small molecule inhibitors of choline kinase for cancer

Study suggests 2004 lawsuit fueled big spending on epilepsy drugs

Adolescent males at increased risk of reporting longtime OTC drug use

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News